Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3993265015 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampin 150 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3993266019 | Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3993267011 | Product containing precisely ethambutol hydrochloride 275 milligram and isoniazid 75 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Is a | Product containing only ethambutol and isoniazid and rifampicin in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Plays role | Antitubercular therapeutic role | false | Inferred relationship | Some | ||
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has manufactured dose form | Oral tablet | true | Inferred relationship | Some | ||
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some | ||
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength numerator value | 275 | false | Inferred relationship | Some | 1 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has basis of strength substance (attribute) | Ethambutol hydrochloride | true | Inferred relationship | Some | 1 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has precise active ingredient | Ethambutol hydrochloride | true | Inferred relationship | Some | 1 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has precise active ingredient | Rifampicin | true | Inferred relationship | Some | 2 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has basis of strength substance (attribute) | Rifampicin | true | Inferred relationship | Some | 2 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Some | 2 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength numerator value | 75 | false | Inferred relationship | Some | 3 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has precise active ingredient | Isoniazid (substance) | true | Inferred relationship | Some | 3 | |
Ethambutol hydrochloride 275 mg and isoniazid 75 mg and rifampicin 150 mg oral tablet | Has basis of strength substance (attribute) | Isoniazid (substance) | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set